Theoretical and spectroscopic studies of anticonvulsant drugs
Identification of Novel Anticonvulsant Drugs using a Larval … · 2016. 12. 15. · F3394-0676 •...
Transcript of Identification of Novel Anticonvulsant Drugs using a Larval … · 2016. 12. 15. · F3394-0676 •...
Simon Hand Vincent Cunliffe (Department of Biomedical Science) Joseph Harrity (Department of Chemistry) Val Gillet (Information School)
Identification of Novel Anticonvulsant Drugs using a Larval Zebrafish Model
Epilepsy Our assay Screening of kinase inhibitors Future work
Epilepsy
• Estimated 50 million cases worldwide
• A neurological syndrome with many clinically distinct subtypes, all of which are characterised by seizures
• Seizures are periods of acute, dysregulated synaptic activity in the brain
Epilepsy
• The currently available anti-epileptic drugs are not effective enough
• 30% of people with epilepsy fail to respond satisfactorily to first line treatments
• Those drugs that are affective have unwanted side effects
Epilepsy
Seizures are attributed to imbalances of excitatory and inhibitory neurotransmitter activities in the brain; glutamate and γ-amino butyric acid (GABA) respectively
Glutamate (+) GABA (-)
Epilepsy
Seizures are attributed to imbalances of excitatory and inhibitory neurotransmitter activities in the brain; glutamate and γ-amino butyric acid (GABA) respectively
Glutamate (+) GABA (-)
Epilepsy
Seizures are attributed to imbalances of excitatory and inhibitory neurotransmitter activities in the brain; glutamate and γ-amino butyric acid (GABA) respectively
Glutamate (+) GABA (-)
Epilepsy
GABA (inhibitory)
Glutamate (excitatory)
Normal neurotransmission
Epilepsy
GABA (inhibitory)
Glutamate (excitatory)
Normal neurotransmission
Epilepsy
GABA (inhibitory)
Glutamate (excitatory)
Normal neurotransmission
Epilepsy
GABA (inhibitory)
Glutamate (excitatory)
In a seizure...
Epilepsy
GABA (inhibitory)
Glutamate (excitatory)
In a seizure...
Seizure
Zebrafish model
– Mapped genome
– Rapid development
– High through-put vertebrate model
– Compounds can be absorbed through aqueous media
– Transparency allows whole mount visualisation of gene expression via in situ hybridisation
• Pentylenetetrazole (PTZ) is a convulsant. Exposure to PTZ triggers a seizure by strong antagonistic action at the GABA A receptor
Santoriello et al. J Clin Invest. 2012;122(7):2337-2343.
The Assay
The Assay
GABA (inhibitory)
Glutamate (excitatory)
transmission of the inhibitory GABA signal is blocked by Pentylenetetrazole (PTZ) inducing a seizure
Seizure
In a PTZ-induced seizure...
The Assay
In a PTZ-induced seizure...
GABA (inhibitory)
Glutamate (excitatory)
Seizure Motor
transmission of the inhibitory GABA signal is blocked by Pentylenetetrazole (PTZ) inducing a seizure
Screening for Anticonvulsants
• A seizure “switches on” particular pattern of gene expression in the brain e.g. cfos gene (right)
• cfos expression after PTZ exposure is not observed if an effective anticonvulsant is administered
• Positive control is the known anticonvulsant Valproic Acid (VPA)
Valproic acid (VPA)
Baxendale et al. Disease Models and Mechanisms, 5, 000-000 (2012)
Screening for Anticonvulsants
• A seizure “switches on” particular pattern of gene expression in the brain e.g. cfos gene (right)
• cfos expression after PTZ exposure is not observed if an effective anticonvulsant is administered
• Positive control is the known anticonvulsant Valproic Acid (VPA)
Valproic acid (VPA)
Baxendale et al. Disease Models and Mechanisms, 5, 000-000 (2012)
Screening of Kinase Inhibitors
• The specific pathways involved in seizures are still largely unknown, but are likely to include kinase enzymes
• Therefore, we tested the hypothesis that kinase inhibition is a valid anticonvulsant strategy
• Target focussed library screening of over 1000 kinase inhibitors
Presence of phosphate group
can be detected by other proteins/cells
Protein Protein
ATP ADP
Kinase activity
+
Screening of Kinase Inhibitors
Compounds screened in a 96 well plate, initially at 25μM
In each well…
In Situ
Miss
or
Hit
PTZ (convulsant)
Potential Anticonvulsant
Screening of Kinase Inhibitors
A hit in the in situ
screen tells us…
Compound has prevented the
seizure
OR
The compound interferes
with gene expression
OR
The larvae are dead
A hit in the locomotor
screen tells us…
Larvae has not has a seizure
OR
Compound is sedative
OR
Compound paralysed larvae
OR
The larvae are dead
Miss (cfos expression)
or
Hit (no cfos expression)
Screening of Kinase Inhibitors
A hit in the in situ
screen tells us…
Compound has prevented the
seizure
OR
The compound interferes
with gene expression
OR
The larvae are dead
A hit in the locomotor
screen tells us…
Larvae has not has a seizure
OR
Compound is sedative
OR
Compound paralysed larvae
OR
The larvae are dead
Miss (cfos expression)
Hit (no cfos expression)
or
Screening of Kinase Inhibitors
42 hits confirmed by in situ repeat screens
As cfos expression can be repressed independently of stopping a seizure (false positive by in situ) anticonvulsant activity must be confirmed independently
10 of the most potent were bought in to test in in locomotor assays
Screening of Kinase Inhibitors
Miss
or
Hit
PTZ (convulsant)
Potential Anticonvulsant
Screening of Kinase Inhibitors
Miss
or
Hit
PTZ (convulsant)
Potential Anticonvulsant
PTZ-induced seizures trigger a large observable increase in motor activity, which can be tracked.
no convulsant PTZ PTZ + effective anticonvulsant
Screening of Kinase Inhibitors
Effective anticonvulsant compounds reduce the distance travelled after PTZ exposure
no convulsant PTZ PTZ + effective anticonvulsant
Screening of Kinase Inhibitors
Effective anticonvulsant compounds reduce the distance travelled after PTZ exposure
no convulsant PTZ PTZ + effective anticonvulsant
Non anticonvulsant Anticonvulsant
Screening of Kinase Inhibitors
6 of 10 hit compounds show significant dose dependant reduction in locomotor activity after PTZ exposure no convulsant PTZ PTZ + effective
anticonvulsant
Non anticonvulsant Anticonvulsant
Screening of Kinase Inhibitors
6 of 10 hit compounds show significant dose dependant reduction in locomotor activity after PTZ exposure no convulsant PTZ PTZ + effective
anticonvulsant
Non anticonvulsant Anticonvulsant
Screening of Kinase Inhibitors
A hit in the In situ
screen tells us…
Brain has not/had a seizure
OR
The compound interferes
with gene expression
OR
The larvae are dead
A hit in the locomotor
screen tells us…
Compound has prevented the seizure
OR
Compound is sedative
OR
Compound paralysed larvae
OR
The larvae are dead
no convulsant PTZ PTZ + effective anticonvulsant
Screening of Kinase Inhibitors
A hit in the In situ
screen tells us…
Brain has not/had a seizure
OR
The compound interferes
with gene expression
OR
The larvae are dead
A hit in the locomotor
screen tells us…
Compound has prevented the seizure
OR
Compound is sedative
OR
Compound paralysed larvae
OR
The larvae are dead
no convulsant PTZ PTZ + effective anticonvulsant
What does each screen tell us?
A hit in the in situ
screen tells us…
Compound has prevented the
seizure
OR
The compound interferes
with gene expression
OR
The larvae are dead
A hit in the locomotor
screen tells us…
Compound has prevented the seizure
OR
Compound is sedative
OR
Compound paralysed larvae
OR
The larvae are dead
What does each screen tell us?
A hit in the in situ
screen tells us…
Compound has prevented the
seizure
OR
The compound interferes
with gene expression
OR
The larvae are dead
A hit in the locomotor
screen tells us…
Compound has prevented the seizure
OR
Compound is sedative
OR
Compound paralysed larvae
OR
The larvae are dead
If a compound stops both the transcriptional and behavioural seizure responses then it is likely that that compound is a true hit
What does each screen tell us?
A hit in the in situ
screen tells us…
Compound has prevented the
seizure
OR
The compound interferes
with gene expression
OR
The larvae are dead
A hit in the locomotor
screen tells us…
Compound has prevented the seizure
OR
Compound is sedative
OR
Compound paralysed larvae
OR
The larvae are dead
OR…
What does each screen tell us?
A hit in the in situ
screen tells us…
Compound has prevented the
seizure
OR
The compound interferes
with gene expression
OR
The larvae are dead
A hit in the locomotor
screen tells us…
Compound has prevented the seizure
OR
Compound is sedative
OR
Compound paralysed larvae
OR
The larvae are dead
Screening of Kinase Inhibitors
In Situ
Miss
or
Hit
PTZ (convulsant)
Potential Anticonvulsant
Screening of Kinase Inhibitors
Miss
or
Hit
Potential Anticonvulsant
• 48hpf embryos have a functional, visible heart
• Effect of compounds on both heart rate and morphology can be observed under microscope
What does each screen tell us?
Normal heart rate
tells us…
Compound is not
toxic
A hit in the locomotor
screen tells us…
Compound has prevented the seizure
OR
Compound is sedative
OR
Compound paralysed larvae
A hit in the In situ
screen tells us…
Compound has
prevented the seizure
OR
The compound
interferes
with gene expression
- thus locomotor and in situ results are valid
What does each screen tell us?
Normal heart rate
tells us…
Compound is not
toxic
AND
Compound has
prevented the seizure
A hit in the locomotor
screen tells us…
Compound has prevented the seizure
OR
Compound is sedative
OR
Compound paralysed larvae
A hit in the In situ
screen tells us…
Compound has
prevented the seizure
OR
The compound
interferes
with gene expression
What does each screen tell us?
Normal heart rate
tells us…
Compound is not
toxic
AND
Compound has
prevented the seizure
A hit in the locomotor
screen tells us…
Compound has prevented the seizure
OR
Compound is sedative
OR
Compound paralysed larvae
A hit in the In situ
screen tells us…
Compound has
prevented the seizure
OR
The compound
interferes
with gene expression
A validated hit compound is one that is not toxic and prevents the behavioural and transcriptional responses to a seizure
Locomotor response to PTZ
In Situ’s
Media alone
PTZ 20uM 10uM 5uM 2.5uM
Hit 9
In Situ’s
Media alone
PTZ 20uM 10uM 5uM 2.5uM
Hit 9
Heart rates
Toxicity
E3
DM
SO
20
uM
1
10
uM
1
2.5
uM
1
5u
M 1
20
uM
2
10
uM
2
5u
M 2
2.5
uM
2
20
uM
3
10
uM
3
5u
M 3
2.5
uM
3
20
uM
4
10
uM
4
5u
M 4
2.5
uM
4
20
uM
5
10
uM
5
5u
M 5
2.5
uM
5
20
uM
6
10
uM
6
5u
M 6
2.5
uM
6
20
uM
7
10
uM
7
5u
M 7
2.5
uM
7
20
uM
8
10
uM
8
5u
M 8
2.5
uM
8
20
uM
9
10
uM
9
5u
M 9
2.5
uM
9
20
uM
10
10
uM
10
5u
M 1
0
2.5
uM
10
0
2 0
4 0
6 0
8 0
1 0 0
A ll C k 1 H its T o x ic ity - 2 4 h p o s t e x p o s u re (3 d p f)
T re a tm e n t
% o
f la
rva
e p
er
co
nd
itio
n
N o rm a l
O dem a
C u rv e d S p in e
O d e m a + C u rv e d s p in e
N o H e a rtb e a t
Best so far – F3394-0676
Media alone
PTZ 20uM 10uM 5uM 2.5uM
cfos
F3394-0676
• 10 analogues of F3394-0676 selected
• Tested in in situ, locomotor and toxicology assays
F3394-0676
• 10 analogues of F3394-0676 selected
• Tested in in situ, locomotor and toxicology assays
Summary
1. Hit identification =
2. Hit confirmation = 3. Hit validation =
4. Hit investigation =
5. Lead identification =
Tim
esc
ale
Can kinase inhibition prevent PTZ-induced seizures?
Are you sure?
Are you really sure?
How do these compounds work?
Can we develop novel compounds that prevent seizures better than those we start with?
Yes
Yes
Something like this…
Yes
Summary
1. Hit identification =
2. Hit confirmation = 3. Hit validation =
4. Hit investigation =
5. Lead identification =
Tim
esc
ale
Can kinase inhibition prevent PTZ-induced seizures? (in situ’s)
Are you sure? (locomotor assays)
Are you really sure? (heart rates)
How do these compounds work?
Can we develop novel compounds that prevent seizures better than those we started with?
Yes
Yes
This way…
Sure enough
Investigation of F3394-0676
• 10 analogues of F3394-0676
• Currently being tested via in situ, locomotor and toxicology assays
Moe 2014.09
Investigation of F3394-0676
• 10 analogues of F3394-0676
• Currently being tested via in situ, locomotor and toxicology assays
Moe 2014.09
Future Work
qPCR- to quantify the transcriptional responses
F3394-0676 kinase inhibition profiling
Searching for compounds that match our pharmacophore of F3394-0676 analogues
Must develop selection criteria to select ligands from, for example, ChEMBL to promote structural diversity
In vivo (zebrafish)
In Silico (modelling)
In situ (Chemistry)
Acknowledgements
Particular thanks to
Vincent Cunliffe
Sarah Baxendale
Joe Harrity
Val Gillet
Acknowledgements
Particular thanks to
Vincent Cunliffe
Sarah Baxendale
Joe Harrity
Val Gillet
…Any Questions?
In Situ’s
Media alone
PTZ 20uM 10uM 5uM 2.5uM
Hit 9
Hit 4